PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung disease |
| Phenotype | C0085655|polymyositis |
| Sentences | 12 |
| PubMedID- 25827843 | Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study. |
| PubMedID- 24800252 | Objective: hyperferritinemia is frequently accompanied by rapidly progressive (rp) interstitial lung disease (ild) with polymyositis (pm)/dermatomyositis (dm). |
| PubMedID- 24142786 | [interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases]. |
| PubMedID- 23423441 | This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease. |
| PubMedID- 22937458 | Here, we reported the clinical history of 3 patients who developed polymyositis complicated by interstitial lung disease (2 cases) and dermatomyositis (1 case), after influenza a (h1n1) vaccination. |
| PubMedID- 20367973 | Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. |
| PubMedID- 23158422 | Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm). |
| PubMedID- 21950266 | Kl-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. |
| PubMedID- 26101728 | Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. |
| PubMedID- 22325787 | Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease. |
| PubMedID- 21285059 | polymyositis associated with severe interstitial lung disease: remission after three doses of iv immunoglobulin. |
| PubMedID- 25297551 | Interstitial lung disease (ild) in patients with polymyositis (pm) and dermatomyositis (dm) is often resistant to treatment and life threatening, being recognized as one of the severest complication in these autoimmune disorders. |
Page: 1